Cooperative Regulation of Coupled Oncoprotein Synthesis and Stability in Triple-Negative Breast Cancer by EGFR and CDK12/13

Using a candidate drug screen, the authors identified that inhibition of cyclin-dependent kinases 12 and 13 (CDK12/13) dramatically sensitized diverse models of TNBC to epidermal growth factor receptor (EGFR) blockade.